{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:13:44Z","timestamp":1773681224705,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Drug-resistant tuberculosis (TB) has emerged as a major challenge toward TB control and prevention. In Lianyungang city, the extent and trend of drug resistant TB is not well known. The objective of the survey was to assess drug resistance pattern of MTB and risk factors for drug resistant TB, including multidrug resistance tuberculosis (MDR-TB) in this area.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed drug susceptibility testing on <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MTB) isolates with first- and second-line anti-tuberculosis drugs of 1012 culture positive TB cases by using the proportion method, who were consecutively enrolled from January 2011 to December 2012 in Lianyungang city, China. The patterns of drug resistance in MTB were investigated and multiple logistic regression analysis was performed to assess the risk factors for drug resistant TB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 1012 strains tested, 308 (30.4%) strains were resistant to at least one first-line drug; the prevalence of MDR-TB was 88 (8.7%), 5 (0.5%) strains were found to be extensively drug-resistant tuberculosis (XDR-TB). Female gender was a risk factor for MDR-TB (adjusted odds ratio (aOR) 1.763, 95% CI (1.060-2.934). The aged 28\u201354\u00a0years was significantly associated with the risk of MDR-TB with an aOR: 2.224, 95% CI (1.158-4.273) when compared with those 65\u00a0years or older. Patients with previous treatment history had a more than 7-fold increased risk of MDR-TB, compared with those never previously treated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The burden of drug resistant TB cases is sizeable, which highlights an urgent need to reinforce control, detection and treatment strategies for drug resistant TB.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-13-1171","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T02:10:46Z","timestamp":1386900646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Rates and risk factors for drug resistance tuberculosis in Northeastern China"],"prefix":"10.1186","volume":"13","author":[{"given":"Qiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongqiao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"key":"6081_CR1","volume-title":"World Health Organization: Global tuberculosis control","author":"WHO","year":"2012","unstructured":"WHO: World Health Organization: Global tuberculosis control. 2012, WHO report, http:\/\/wwww.hoint\/tb\/publications\/global_report\/gtbr12_mainpdf 2012, website WHO report"},{"issue":"23","key":"6081_CR2","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X: National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012, 366 (23): 2161-2170.","journal-title":"N Engl J Med"},{"issue":"1","key":"6081_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1574-6968.2007.00658.x","volume":"270","author":"T Iwamoto","year":"2007","unstructured":"Iwamoto T, Yoshida S, Suzuki K, Tomita M, Fujiyama R, Tanaka N, Kawakami Y, Ito M: Hypervariable loci that enhance the discriminatory ability of newly proposed 15\u2012loci and 24\u2012loci variable\u2012number tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. FEMS Microbiol Lett. 2007, 270 (1): 67-74.","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"6081_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/oxfordjournals.aje.a009822","volume":"149","author":"J Glynn","year":"1999","unstructured":"Glynn J, Vyonycky E, Fine P: Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol. 1999, 149 (4): 366-371.","journal-title":"Am J Epidemiol"},{"key":"6081_CR5","volume-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response","author":"WH Organization","year":"2010","unstructured":"Organization WH: Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. 2010, Geneva: World Health Organization"},{"issue":"8","key":"6081_CR6","first-page":"967","volume":"14","author":"T Chonde","year":"2010","unstructured":"Chonde T, Basra D, Mfinanga S, Range N, Lwilla F, Shirima R, Van Deun A, Zignol M, Cobelens F, Egwaga S: National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis. 2010, 14 (8): 967-972.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"6081_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1684-1182(10)60045-X","volume":"43","author":"C-C Yu","year":"2010","unstructured":"Yu C-C, Chang C-Y, Liu C-E, Shih L-F, Hsiao J-H, Chen C-H: Drug resistance pattern of <i> mycobacterium tuberculosis<\/i> complex at a Medical Center in Central Taiwan, 2003\u20132007. J Microbiol Immunol Infect. 2010, 43 (4): 285-290.","journal-title":"J Microbiol Immunol Infect"},{"key":"6081_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2458-11-110","volume":"11","author":"Y Shao","year":"2011","unstructured":"Shao Y, Yang D, Xu W, Lu W, Song H, Dai Y, Shen H, Wang J: Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead. BMC Public Health. 2011, 11: 110-","journal-title":"BMC Public Health"},{"key":"6081_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2334-11-288","volume":"11","author":"Q Liu","year":"2011","unstructured":"Liu Q, Yang D, Xu W, Wang J, Lv B, Shao Y, Song H, Li G, Dong H, Wan K, et al: Molecular typing of mycobacterium tuberculosis isolates circulating in Jiangsu Province, China. BMC Infect Dis. 2011, 11: 288-","journal-title":"BMC Infect Dis"},{"issue":"5","key":"6081_CR10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.5588\/ijtld.11.0507","volume":"16","author":"X Li","year":"2012","unstructured":"Li X, Wang H, Jing H, Wang Y, Yu C, Wang J, Liu Z, Graviss E, Ma X: Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China [Short communication]. Int J Tuberc Lung Dis. 2012, 16 (5): 612-614.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"6081_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/mdr.2008.0823","volume":"14","author":"Y Hu","year":"2008","unstructured":"Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B: Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb Drug Resist. 2008, 14 (3): 227-232.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"6081_CR12","first-page":"253","volume":"13","author":"X Shen","year":"2009","unstructured":"Shen X, DeRiemer K, Yuan Z-A, Shen M, Xia Z, Gui X, Wang L, Gao Q, Mei J: Drug-resistant tuberculosis in Shanghai, China, 2000\u20132006: prevalence, trends and risk factors. Int J Tuberc Lung Dis. 2009, 13 (2): 253-259.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"6081_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3346\/jkms.2007.22.4.677","volume":"22","author":"JC Choi","year":"2007","unstructured":"Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Lee NY, Park YK, Bai GH, Koh W-J: Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci. 2007, 22 (4): 677-681.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"6081_CR14","first-page":"62","volume":"13","author":"L Chac\u00f3n","year":"2009","unstructured":"Chac\u00f3n L, La\u00ednez M, Rosales E, Mercado M, Caminero J: Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua. Int J Tuberc Lung Dis. 2009, 13 (1): 62-67.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"6081_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1532-5415.1992.tb01941.x","volume":"40","author":"T Yoshikawa","year":"1992","unstructured":"Yoshikawa T: Tuberculosis in aging adults. J Am Geriatr Soc. 1992, 40 (2): 178-","journal-title":"J Am Geriatr Soc"},{"issue":"9678","key":"6081_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","volume":"373","author":"A Wright","year":"2009","unstructured":"Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D: Epidemiology of antituberculosis drug resistance 2002\u201307: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009, 373 (9678): 1861-1873.","journal-title":"Lancet"},{"issue":"8","key":"6081_CR17","first-page":"869","volume":"12","author":"J Caminero","year":"2008","unstructured":"Caminero J: Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation [Review article]. Int J Tuberc Lung Dis. 2008, 12 (8): 869-877.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"6081_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrmicro2048","volume":"7","author":"C Dye","year":"2009","unstructured":"Dye C: Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol. 2009, 7 (1): 81-87.","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"6081_CR19","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/522537","volume":"45","author":"H-R Kim","year":"2007","unstructured":"Kim H-R, Hwang SS, Kim HJ, Lee SM, Yoo C-G, Kim YW, Han SK, Shim Y-S, Yim J-J: Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2007, 45 (10): 1290-1295.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"6081_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1086\/590009","volume":"47","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J: Extensively drug-resistant tuberculosis in California, 1993\u20132006. Clin Infect Dis. 2008, 47 (4): 450-457.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6081_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/JCM.43.1.95-100.2005","volume":"43","author":"R Jou","year":"2005","unstructured":"Jou R, Chiang CY, Huang WL: Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol. 2005, 43 (1): 95-100.","journal-title":"J Clin Microbiol"},{"key":"6081_CR22","volume-title":"Engaging all health care providers in TB control: guidance on implementing public-private mix approaches","author":"Organization WH","year":"2006","unstructured":"Organization WH: Engaging all health care providers in TB control: guidance on implementing public-private mix approaches. 2006, Geneva: World Health Organization"},{"issue":"1","key":"6081_CR23","first-page":"31","volume":"8","author":"T Yoshiyama","year":"2004","unstructured":"Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T: Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Int J Tuberc Lung Dis. 2004, 8 (1): 31-38.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6081_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","volume":"149","author":"W Lew","year":"2008","unstructured":"Lew W, Pai M, Oxlade O: Initial drug resistance and tuberculosis treatment outcomes. Ann Intern Med. 2008, 149: 123-134.","journal-title":"Ann Intern Med"},{"issue":"3","key":"6081_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1164\/rccm.200802-240OC","volume":"178","author":"A Mak","year":"2008","unstructured":"Mak A, Thomas A, del Granado M, Zaleskis R, Mouzafarova N, Menzies D: Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am J Respir Crit Care Med. 2008, 178 (3): 306-312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"6081_CR26","first-page":"1148","volume":"13","author":"L Vashakidze","year":"2009","unstructured":"Vashakidze L, Salakaia A, Shubladze N, Cynamon M, Barbakadze K, Kikvidze M, Papitashvili L, Nonikashvili M, Solomonia N, Bejanishvili N: Prevalence and risk factors for drug resistance among hospitalized TB patients in Georgia. Int J Tuberc Lung Dis. 2009, 13 (9): 1148-","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"6081_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijid.2008.03.012","volume":"12","author":"N Mdivani","year":"2008","unstructured":"Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Jibuti T, Shubladze N, Kutateladze T, Khechinashvili G, del Rio C, Salakaia A: High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis. 2008, 12 (6): 635-","journal-title":"Int J Infect Dis"},{"issue":"5","key":"6081_CR28","first-page":"406","volume":"6","author":"O Toungoussova","year":"2002","unstructured":"Toungoussova O, Caugant D, Sandven P, Mariandyshev A, Bjune G: Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis. 2002, 6 (5): 406-414.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"6081_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/318489","volume":"32","author":"S Lockman","year":"2001","unstructured":"Lockman S, Kruuner A, Binkin NJ, Levina K, Wang YC, Danilovitsh M, Hoffner SE, Tappero JW: Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Clin Infect Dis. 2001, 32 (3): 373-380.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"6081_CR30","first-page":"1006","volume":"9","author":"C Chiang","year":"2005","unstructured":"Chiang C, Chang C, Chang R, Li C, Huang R: Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis. 2005, 9 (9): 1006-1012.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"6081_CR31","first-page":"388","volume":"3","author":"NH Long","year":"1999","unstructured":"Long NH, Johansson E, Lonnroth K, Eriksson B, Winkvist A, Diwan V: Longer delays in tuberculosis diagnosis among women in Vietnam. Int J Tuberc Lung Dis. 1999, 3 (5): 388-393.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"6081_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/524017","volume":"46","author":"CY Jeon","year":"2008","unstructured":"Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH: Extensively drug\u2012resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis. 2008, 46 (1): 42-49.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"6081_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","volume":"61","author":"A Faustini","year":"2006","unstructured":"Faustini A, Hall AJ, Perucci CA: Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006, 61 (2): 158-163.","journal-title":"Thorax"},{"issue":"9","key":"6081_CR34","first-page":"1065","volume":"12","author":"W Law","year":"2008","unstructured":"Law W, Yew W, Chiu Leung C, Kam K, Tam C, Chan C, Leung C: Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2008, 12 (9): 1065-1070.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"6081_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0102-35862003000200008","volume":"29","author":"EC Barroso","year":"2003","unstructured":"Barroso EC, Mota RMS, Santos RO, Sousa ALO, Barroso JB, Rodrigues JLN: Risk factors for acquired multidrug-resistant tuberculosis. J Pneumol. 2003, 29 (2): 89-97.","journal-title":"J Pneumol"},{"issue":"9547","key":"6081_CR36","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006, 368 (9547): 1575-1580.","journal-title":"Lancet"},{"issue":"9","key":"6081_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3201\/eid1409.061524","volume":"14","author":"YB Amor","year":"2008","unstructured":"Amor YB, Nemser B, Singh A, Sankin A, Schluger N: Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg Infect Dis. 2008, 14 (9): 1345-","journal-title":"Emerg Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-1171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-13-1171\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-1171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-1171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:26:47Z","timestamp":1630549607000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-1171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["6081"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-13-1171","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"6 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1171"}}